Recently, Li et al. (2022) reported that SLAMF3 and SLAMF4 are immune checkpoints that constrain macrophage phagocytosis of hematopoietic tumors [56]. The gene discussed is LY9; the disease is hematopoietic and lymphoid cell neoplasm.